Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (41-50 of 519) with videos related to

Pageof 52
Sort By:
Progress in Molecular Biology and Translational Science|November 16, 2010
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinicJian Zhang, Lalit Patel, Kenneth J Pienta
Journal of Cellular Biochemistry|January 27, 2009
Prostate cancer promotes CD11b positive cells to differentiate into osteoclastsKosuke Mizutani, Sudha Sud, Kenneth J Pienta
The Journal of Biological Chemistry|July 10, 2008
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationHernan Roca, Zachary Varsos, Kenneth J Pienta
Interface Focus|August 7, 2014
Critical transitions in a game theoretic model of tumour metabolismArdeshir Kianercy, Robert Veltri, Kenneth J Pienta
Oncotarget|May 15, 2018
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophagesAmber E de Groot, Kenneth J Pienta
Cancer Metastasis Reviews|January 4, 2023
Dormant cancer cells: programmed quiescence, senescence, or both?Kevin Truskowski, Sarah R Amend, Kenneth J Pienta
Clinical and Translational Science|September 3, 2011
The Clinical and Translational Science Awards (CTSAs) are transforming the way academic medical institutions approach translational research: the University of Michigan ExperienceKenneth J Pienta, Alison L Spork, Joan Scheske
International Journal of Molecular Sciences|September 13, 2025
Methods and Guidelines for Metabolism Studies: Applications to Cancer ResearchMelvin Li, Sarah R Amend, Kenneth J Pienta
Current Opinion in Oncology|February 19, 2021
Understanding the tumor-immune microenvironment in prostate cancerLiang Dong, Kayla V Myers, Kenneth J Pienta
Neoplasia (New York, N.Y.)|December 19, 2009
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cellsHernan Roca, Zachary S Varsos, Kenneth J Pienta
Pageof 52

Showing results (41-50 of 519) with videos related to

Sort By:
Pageof 52
Progress in Molecular Biology and Translational Science|November 16, 2010
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinicJian Zhang, Lalit Patel, Kenneth J Pienta
Journal of Cellular Biochemistry|January 27, 2009
Prostate cancer promotes CD11b positive cells to differentiate into osteoclastsKosuke Mizutani, Sudha Sud, Kenneth J Pienta
The Journal of Biological Chemistry|July 10, 2008
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationHernan Roca, Zachary Varsos, Kenneth J Pienta
Interface Focus|August 7, 2014
Critical transitions in a game theoretic model of tumour metabolismArdeshir Kianercy, Robert Veltri, Kenneth J Pienta
Oncotarget|May 15, 2018
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophagesAmber E de Groot, Kenneth J Pienta
Cancer Metastasis Reviews|January 4, 2023
Dormant cancer cells: programmed quiescence, senescence, or both?Kevin Truskowski, Sarah R Amend, Kenneth J Pienta
Clinical and Translational Science|September 3, 2011
The Clinical and Translational Science Awards (CTSAs) are transforming the way academic medical institutions approach translational research: the University of Michigan ExperienceKenneth J Pienta, Alison L Spork, Joan Scheske
International Journal of Molecular Sciences|September 13, 2025
Methods and Guidelines for Metabolism Studies: Applications to Cancer ResearchMelvin Li, Sarah R Amend, Kenneth J Pienta
Current Opinion in Oncology|February 19, 2021
Understanding the tumor-immune microenvironment in prostate cancerLiang Dong, Kayla V Myers, Kenneth J Pienta
Neoplasia (New York, N.Y.)|December 19, 2009
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cellsHernan Roca, Zachary S Varsos, Kenneth J Pienta
Pageof 52